{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "64-year-old male diagnosed in August 2020 with stage 3A left non-small cell lung cancer (NSCLC).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Lung Cancer",
              "status": "active",
              "onset_date": "2020-08"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Positron emission tomography (PET) scan at diagnosis showed a large left hilar mass, with small mediastinal nodes.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Positron emission tomography",
              "body_part": "hilar mass",
              "modality": "PET",
              "finding": "large left hilar mass, with small mediastinal nodes",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Endobronchial ultrasound (EBUS) guided biopsy confirmed carcinoma. Immunohistochemistry (IHC) was positive for P40 and negative for thyroid transcription factor 1 (TTF-1), consistent with squamous cell carcinoma.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0007144",
              "label": "Carcinoma",
              "status": "active"
            },
            {
              "code": "C0038353",
              "label": "Squamous Cell Carcinoma",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "C1517259",
              "approach": "endoscopic",
              "location": "bronchial tree",
              "outcome": "positive for carcinoma"
            }
          ],
          "labs": [
            {
              "test": "P40",
              "value": "positive"
            },
            {
              "test": "Thyroid Transcription Factor-1",
              "value": "negative"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "PD-L1 expression was low at 20%.",
        "clinical_data": {}
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Patient received 6 weeks of definitive concurrent chemo-radiotherapy with weekly carboplatin and paclitaxel.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0007127",
              "dosage": null,
              "frequency": "weekly",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0030382",
              "dosage": null,
              "frequency": "weekly",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0034329",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient developed a mild infusion reaction to the last two doses of paclitaxel, requiring steroid pre-medications. Eosinophil count was normal.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0030395",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0037994",
              "dosage": null,
              "frequency": "pre-medication",
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0010054"
            }
          ],
          "labs": [
            {
              "test": "C0014479",
              "value": "normal",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            }
          ],
          "allergies": [
            {
              "substance": "C0030395",
              "reaction": "C0010054",
              "severity": "mild",
              "date_recorded": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "PET scan and brain magnetic resonance imaging (MRI) at completion of chemo-radiotherapy showed good response to treatment.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Positron emission tomography",
              "body_part": "Brain",
              "modality": "PET",
              "finding": "good response to treatment",
              "date": null
            },
            {
              "type": "Magnetic resonance imaging",
              "body_part": "Brain",
              "modality": "MRI",
              "finding": "good response to treatment",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Patient commenced two weekly maintenance therapy with durvalumab in October 2020.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C3828744",
              "dosage": null,
              "frequency": "two weekly",
              "modality": null,
              "start_date": "2020-10",
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "After the first dose of durvalumab, routine blood work-up showed eosinophilia of 5.4 \u00d7 109/L.",
        "clinical_data": {
          "labs": [
            {
              "test": "Eosinophils",
              "value": "5.4",
              "unit": "10^9/L",
              "flag": "abnormal"
            }
          ],
          "medications": [
            {
              "drug": "Durvalumab",
              "indication": "Unknown"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Initial diagnosis and staging of lung cancer."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Biopsy to confirm the type of lung cancer."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "PD-L1 expression level assessment."
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Initiation of chemo-radiotherapy treatment."
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Adverse reaction to paclitaxel during chemo-radiotherapy."
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Assessment of treatment response via PET scan and brain MRI."
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Commencement of maintenance therapy with durvalumab.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C3828744"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Development of eosinophilia after the first dose of durvalumab.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0014479"
          ],
          "change_type": "progression",
          "target_domain": "lab"
        }
      }
    }
  ]
}